Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes

Andrew L. Kau; Phillip E. Korenblat

doi:10.1097/ACI.0000000000000108

Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes

Andrew L. Kau
, Phillip E. Korenblat

Research output: Contribution to journal › Review article › peer-review

53 Scopus citations

Abstract

Anti-IL-4/13 therapies, guided by knowledge of an individual's underlying pathophysiology, are a promising class of therapies for treatment of asthma.

Original language	English
Pages (from-to)	570-575
Number of pages	6
Journal	Current opinion in allergy and clinical immunology
Volume	14
Issue number	6
DOIs	https://doi.org/10.1097/ACI.0000000000000108
State	Published - 2014

Keywords

Asthma
IL-13
IL-4
Monoclonal antibody

Access to Document

10.1097/ACI.0000000000000108

Cite this

@article{808a4ebbb79e4af688beec82c2b1c44e,

title = "Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes",

abstract = "Anti-IL-4/13 therapies, guided by knowledge of an individual's underlying pathophysiology, are a promising class of therapies for treatment of asthma.",

keywords = "Asthma, IL-13, IL-4, Monoclonal antibody",

author = "Kau, \{Andrew L.\} and Korenblat, \{Phillip E.\}",

note = "Publisher Copyright: Copyright {\textcopyright} Lippincott Williams \& Wilkins.",

year = "2014",

doi = "10.1097/ACI.0000000000000108",

language = "English",

volume = "14",

pages = "570--575",

journal = "Current opinion in allergy and clinical immunology",

issn = "1528-4050",

number = "6",

}

TY - JOUR

T1 - Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes

AU - Kau, Andrew L.

AU - Korenblat, Phillip E.

PY - 2014

Y1 - 2014

N2 - Anti-IL-4/13 therapies, guided by knowledge of an individual's underlying pathophysiology, are a promising class of therapies for treatment of asthma.

AB - Anti-IL-4/13 therapies, guided by knowledge of an individual's underlying pathophysiology, are a promising class of therapies for treatment of asthma.

KW - Asthma

KW - IL-13

KW - IL-4

KW - Monoclonal antibody

UR - https://www.scopus.com/pages/publications/84927618165

U2 - 10.1097/ACI.0000000000000108

DO - 10.1097/ACI.0000000000000108

M3 - Review article

C2 - 25159182

AN - SCOPUS:84927618165

SN - 1528-4050

VL - 14

SP - 570

EP - 575

JO - Current opinion in allergy and clinical immunology

JF - Current opinion in allergy and clinical immunology

IS - 6

ER -

Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this